Article (Scientific journals)
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.
Trepte, Philipp; Secker, Christopher; Olivet, Julien et al.
2024In Molecular Systems Biology, 20 (4), p. 428 - 457
Peer Reviewed verified by ORBi
 

Files


Full Text
Trepte et al 2024.pdf
Author postprint (10.63 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
AlphaFold; Machine Learning; Protein–Protein Interactions; SARS-CoV-2; VirtualFlow; Methyltransferases; Humans; Methyltransferases/metabolism; Artificial Intelligence; Drug Discovery; SARS-CoV-2/metabolism; COVID-19; Applied Mathematics; Computational Theory and Mathematics; General Agricultural and Biological Sciences; General Immunology and Microbiology; General Biochemistry, Genetics and Molecular Biology; Information Systems
Abstract :
[en] Protein-protein interactions (PPIs) offer great opportunities to expand the druggable proteome and therapeutically tackle various diseases, but remain challenging targets for drug discovery. Here, we provide a comprehensive pipeline that combines experimental and computational tools to identify and validate PPI targets and perform early-stage drug discovery. We have developed a machine learning approach that prioritizes interactions by analyzing quantitative data from binary PPI assays or AlphaFold-Multimer predictions. Using the quantitative assay LuTHy together with our machine learning algorithm, we identified high-confidence interactions among SARS-CoV-2 proteins for which we predicted three-dimensional structures using AlphaFold-Multimer. We employed VirtualFlow to target the contact interface of the NSP10-NSP16 SARS-CoV-2 methyltransferase complex by ultra-large virtual drug screening. Thereby, we identified a compound that binds to NSP10 and inhibits its interaction with NSP16, while also disrupting the methyltransferase activity of the complex, and SARS-CoV-2 replication. Overall, this pipeline will help to prioritize PPI targets to accelerate the discovery of early-stage drug candidates targeting protein complexes and pathways.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Trepte, Philipp  ;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. philipp.trepte@imba.oeaw.ac.at ; Brain Development and Disease, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030, Vienna, Austria. philipp.trepte@imba.oeaw.ac.at
Secker, Christopher  ;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. secker@zib.de ; Zuse Institute Berlin, Berlin, Germany. secker@zib.de
Olivet, Julien   ;  Université de Liège - ULiège > GIGA > GIGA Molecular Biology of Diseases - Viral Interactomes Network ; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Structural Biology Unit, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Katholieke Universiteit Leuven, 3000, Leuven, Belgium
Blavier, Jeremy   ;  Université de Liège - ULiège > GIGA > GIGA Molecular Biology of Diseases - Viral Interactomes Network
Kostova, Simona;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Maseko, Sibusiso Bonginkhost  ;  Université de Liège - ULiège > Département GxABT > Microbial technologies
Minia, Igor;  RNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, 13125, Berlin, Germany
Silva Ramos, Eduardo ;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Cassonnet, Patricia;  Département de Virologie, Unité de Génétique Moléculaire des Virus à ARN (GMVR), Institut Pasteur, Centre National de la Recherche Scientifique (CNRS), Université de Paris, Paris, France
Golusik, Sabrina;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Zenkner, Martina;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Beetz, Stephanie;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Liebich, Mara J;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Scharek, Nadine;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Schütz, Anja ;  Protein Production & Characterization, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany
Sperling, Marcel ;  Multifunctional Colloids and Coating, Fraunhofer Institute for Applied Polymer Research (IAP), 14476, Potsdam-Golm, Germany
Lisurek, Michael ;  Structural Chemistry and Computational Biophysics, Leibniz-Institut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany
Wang, Yang;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
Spirohn, Kerstin;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
Hao, Tong;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
Calderwood, Michael A ;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
Hill, David E ;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
Landthaler, Markus ;  RNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, 13125, Berlin, Germany ; Institute of Biology, Humboldt-Universität zu Berlin, 13125, Berlin, Germany
Choi, Soon Gang ;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. soongangchoi@gmail.com ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. soongangchoi@gmail.com ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. soongangchoi@gmail.com
Twizere, Jean-Claude   ;  Université de Liège - ULiège > GIGA > GIGA Molecular Biology of Diseases - Viral Interactomes Network
Vidal, Marc  ;  Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. marc_vidal@dfci.harvard.edu ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. marc_vidal@dfci.harvard.edu
Wanker, Erich E  ;  Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. erich.w@mdc-berlin.de
More authors (17 more) Less
 These authors have contributed equally to this work.
Language :
English
Title :
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.
Publication date :
April 2024
Journal title :
Molecular Systems Biology
ISSN :
1744-4292
Publisher :
Springer Science and Business Media LLC, England
Volume :
20
Issue :
4
Pages :
428 - 457
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
LabEx IBEID (Biologie Intégrative des Maladies Infectieuses Emergentes)
Funders :
BMBF - Bundesministerium für Bildung und Forschung
HGF - Helmholtz Association of German Research Centres
CHDI Foundation
DKTK - Deutschen Konsortium für Translationale Krebsforschung
DFG - Deutsche Forschungsgemeinschaft
F.R.S.-FNRS - Fonds de la Recherche Scientifique
WBI - Wallonia-Brussels International
NIH - National Institutes of Health
Deutsche Krebshilfe
Funding number :
Claudia Adams Barr Award; Wallonia-Brussels International (WBI)-World Excellence Fellowship
Available on ORBi :
since 18 May 2024

Statistics


Number of views
49 (6 by ULiège)
Number of downloads
127 (5 by ULiège)

Scopus citations®
 
6
Scopus citations®
without self-citations
6
OpenAlex citations
 
5

Bibliography


Similar publications



Contact ORBi